ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,851.70
0.00%
S&P ASX All Technology
3,077.90
0.00%
Brent Oil
82.445
-1.30%
US Dollar vs AUD
1.49921
0.02%
Bitcoin
70,199.72
-1.79%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) News

ASMB

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASMB
DateTimeSourceHeadlineSymbolCompany
09/05/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
09/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
09/05/202406:05GlobeNewswire Inc.Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
29/03/202407:05GlobeNewswire Inc.Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
09/02/202400:00GlobeNewswire Inc.Assembly Biosciences Announces Effective Date of Reverse Stock SplitNASDAQ:ASMBAssembly Biosciences Inc
03/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
20/01/202403:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
18/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
05/01/202400:00GlobeNewswire Inc.Assembly Biosciences Provides Anticipated Development Milestones for 2024NASDAQ:ASMBAssembly Biosciences Inc
22/12/202308:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ASMBAssembly Biosciences Inc
22/12/202308:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
12/12/202308:10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
12/12/202308:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
08/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
23/11/202308:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
23/11/202308:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
11/11/202308:05GlobeNewswire Inc.Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ASMBAssembly Biosciences Inc
11/11/202300:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
09/11/202308:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
09/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
09/11/202308:05GlobeNewswire Inc.Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
09/11/202300:00GlobeNewswire Inc.Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical OfficerNASDAQ:ASMBAssembly Biosciences Inc
04/11/202307:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
01/11/202307:19Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ASMBAssembly Biosciences Inc
01/11/202303:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/10/202323:44Dow Jones NewsAssembly Biosciences Shares Soar Premarket on Gilead PactNASDAQ:ASMBAssembly Biosciences Inc
17/10/202322:51Dow Jones NewsGilead Taking Stake in Assembly Bio Under Antiviral CollaborationNASDAQ:ASMBAssembly Biosciences Inc
17/10/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
17/10/202322:00Business WireGilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral DiseasesNASDAQ:ASMBAssembly Biosciences Inc
11/10/202323:00GlobeNewswire Inc.Assembly Biosciences to Present New Data at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ASMB

Your Recent History

FX
EURAUD
Euro vs AUD
ASX
XAO
Australian SE All Ordina...
ASX
WBC
Westpac Banking
NYSE
MCD
McDonalds
ASX
WOW
Woolworths
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
FX
AUDJPY
AUD vs Yen
ASX
XMM
S&P ASX 300 Metals and M...
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved